Shuji Ogino

Shuji Ogino has advanced understanding of vitamin D in cancer through molecular pathological epidemiology, examining how vitamin D status interacts with specific tumor molecular subtypes and the immune microenvironment. His research has shown that vitamin D affects cancer outcomes differently depending on tumor VDR expression and immune cell infiltration patterns. This precision approach to vitamin D-cancer relationships has opened new avenues for identifying which patients may benefit most from supplementation.